GB9424013D0 - Medicaments - Google Patents
MedicamentsInfo
- Publication number
- GB9424013D0 GB9424013D0 GB9424013A GB9424013A GB9424013D0 GB 9424013 D0 GB9424013 D0 GB 9424013D0 GB 9424013 A GB9424013 A GB 9424013A GB 9424013 A GB9424013 A GB 9424013A GB 9424013 D0 GB9424013 D0 GB 9424013D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- medicaments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9424013A GB9424013D0 (en) | 1994-11-29 | 1994-11-29 | Medicaments |
JP8517131A JPH10509722A (en) | 1994-11-29 | 1995-11-29 | Use of rifabutin in the treatment of Pneumocystis carinii infection and combination of rifabutin with atovaquone |
EP95938501A EP0794776A2 (en) | 1994-11-29 | 1995-11-29 | Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections |
AU39871/95A AU3987195A (en) | 1994-11-29 | 1995-11-29 | Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections |
PCT/GB1995/002790 WO1996016652A2 (en) | 1994-11-29 | 1995-11-29 | Use of rifabutin and a combination of rifabutin and atovaquone in the treatment of pneumocystis carinii infections |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9424013A GB9424013D0 (en) | 1994-11-29 | 1994-11-29 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9424013D0 true GB9424013D0 (en) | 1995-01-18 |
Family
ID=10765105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9424013A Pending GB9424013D0 (en) | 1994-11-29 | 1994-11-29 | Medicaments |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0794776A2 (en) |
JP (1) | JPH10509722A (en) |
AU (1) | AU3987195A (en) |
GB (1) | GB9424013D0 (en) |
WO (1) | WO1996016652A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2016010799A (en) * | 2014-02-19 | 2017-01-23 | Texas A & M Univ Sys | Compositions and methods for drug sensitization of parasites. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9224739D0 (en) * | 1992-11-26 | 1993-01-13 | Wellcome Found | Medicaments |
GB9226905D0 (en) * | 1992-12-24 | 1993-02-17 | Wellcome Found | Pharmaceutical preparation |
CA2138643A1 (en) * | 1993-05-05 | 1994-11-10 | Jack S. Remington | Use of rifamycin derivatives for the manufacture of a medicament for the treatment of toxoplasmosis |
-
1994
- 1994-11-29 GB GB9424013A patent/GB9424013D0/en active Pending
-
1995
- 1995-11-29 JP JP8517131A patent/JPH10509722A/en active Pending
- 1995-11-29 AU AU39871/95A patent/AU3987195A/en not_active Abandoned
- 1995-11-29 EP EP95938501A patent/EP0794776A2/en not_active Withdrawn
- 1995-11-29 WO PCT/GB1995/002790 patent/WO1996016652A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU3987195A (en) | 1996-06-19 |
JPH10509722A (en) | 1998-09-22 |
WO1996016652A2 (en) | 1996-06-06 |
EP0794776A2 (en) | 1997-09-17 |
WO1996016652A3 (en) | 1996-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3032245T3 (en) | Medicaments | |
GB9606805D0 (en) | Medicaments | |
GB9406573D0 (en) | Medicaments | |
GB9420784D0 (en) | Medicaments | |
GB9611947D0 (en) | Medicaments | |
GB9605293D0 (en) | Medicaments | |
GB9618974D0 (en) | Medicaments | |
GB9418530D0 (en) | Medicaments | |
GB9421133D0 (en) | Medicaments | |
GB9411052D0 (en) | Medicaments | |
GB9416365D0 (en) | Medicaments | |
GB9611167D0 (en) | Medicaments | |
GB9613096D0 (en) | Medicaments | |
GB9424013D0 (en) | Medicaments | |
EP0790829A4 (en) | Medicaments | |
GB9416127D0 (en) | Medicaments | |
GB9411606D0 (en) | Medicaments | |
GB9420699D0 (en) | Medicaments | |
GB9420704D0 (en) | Medicaments | |
GB9420762D0 (en) | Medicaments | |
GB9416645D0 (en) | Medicaments | |
GB9416158D0 (en) | Medicaments | |
GB9423098D0 (en) | Medicaments | |
GB9416126D0 (en) | Medicaments | |
GB9425055D0 (en) | Medicaments |